The proportion of breast cancers in the general population attributed to BRCA1 and BRCA2 germline pathogenic variants is approximately 5–10% [1, 2], but this proportion is much higher (up to 55%) in selected families referred to familial cancer clinics [3]. This evidence concerns the gene BRCA2 and breast carcinoma.